Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry

Lydia M. Young, Janet C. Saunders, Rachel A. Mahood, Charlotte H. Revill, Richard J. Foster, Ling Hsien Tu, Daniel P. Raleigh, Sheena E. Radford, Alison E. Ashcroft

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

The search for therapeutic agents that bind specifically to precursor protein conformations and inhibit amyloid assembly is an important challenge. Identifying such inhibitors is difficult because many protein precursors of aggregation are partially folded or intrinsically disordered, which rules out structure-based design. Furthermore, inhibitors can act by a variety of mechanisms, including specific or nonspecific binding, as well as colloidal inhibition. Here we report a high-throughput method based on ion mobility spectrometry-mass spectrometry (IMS-MS) that is capable of rapidly detecting small molecules that bind to amyloid precursors, identifying the interacting protein species and defining the mode of inhibition. Using this method we have classified a variety of small molecules that are potential inhibitors of human islet amyloid polypeptide (hIAPP) aggregation or amyloid-beta 1-40 aggregation as specific, nonspecific, colloidal or non-interacting. We also demonstrate the ability of IMS-MS to screen for inhibitory small molecules in a 96-well plate format and use this to discover a new inhibitor of hIAPP amyloid assembly.

Original languageEnglish
Pages (from-to)73-81
Number of pages9
JournalNature Chemistry
Volume7
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Amyloid
Spectrometry
Islet Amyloid Polypeptide
Mass spectrometry
Screening
Protein Precursors
Agglomeration
Ions
Molecules
Polypeptides
Proteins
Conformations
Throughput

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry. / Young, Lydia M.; Saunders, Janet C.; Mahood, Rachel A.; Revill, Charlotte H.; Foster, Richard J.; Tu, Ling Hsien; Raleigh, Daniel P.; Radford, Sheena E.; Ashcroft, Alison E.

In: Nature Chemistry, Vol. 7, No. 1, 01.01.2015, p. 73-81.

Research output: Contribution to journalArticle

Young, LM, Saunders, JC, Mahood, RA, Revill, CH, Foster, RJ, Tu, LH, Raleigh, DP, Radford, SE & Ashcroft, AE 2015, 'Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry', Nature Chemistry, vol. 7, no. 1, pp. 73-81. https://doi.org/10.1038/nchem.2129
Young, Lydia M. ; Saunders, Janet C. ; Mahood, Rachel A. ; Revill, Charlotte H. ; Foster, Richard J. ; Tu, Ling Hsien ; Raleigh, Daniel P. ; Radford, Sheena E. ; Ashcroft, Alison E. / Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry. In: Nature Chemistry. 2015 ; Vol. 7, No. 1. pp. 73-81.
@article{fa00636515d7405f98d969d9104a797a,
title = "Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry",
abstract = "The search for therapeutic agents that bind specifically to precursor protein conformations and inhibit amyloid assembly is an important challenge. Identifying such inhibitors is difficult because many protein precursors of aggregation are partially folded or intrinsically disordered, which rules out structure-based design. Furthermore, inhibitors can act by a variety of mechanisms, including specific or nonspecific binding, as well as colloidal inhibition. Here we report a high-throughput method based on ion mobility spectrometry-mass spectrometry (IMS-MS) that is capable of rapidly detecting small molecules that bind to amyloid precursors, identifying the interacting protein species and defining the mode of inhibition. Using this method we have classified a variety of small molecules that are potential inhibitors of human islet amyloid polypeptide (hIAPP) aggregation or amyloid-beta 1-40 aggregation as specific, nonspecific, colloidal or non-interacting. We also demonstrate the ability of IMS-MS to screen for inhibitory small molecules in a 96-well plate format and use this to discover a new inhibitor of hIAPP amyloid assembly.",
author = "Young, {Lydia M.} and Saunders, {Janet C.} and Mahood, {Rachel A.} and Revill, {Charlotte H.} and Foster, {Richard J.} and Tu, {Ling Hsien} and Raleigh, {Daniel P.} and Radford, {Sheena E.} and Ashcroft, {Alison E.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/nchem.2129",
language = "English",
volume = "7",
pages = "73--81",
journal = "Nature Chemistry",
issn = "1755-4330",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry

AU - Young, Lydia M.

AU - Saunders, Janet C.

AU - Mahood, Rachel A.

AU - Revill, Charlotte H.

AU - Foster, Richard J.

AU - Tu, Ling Hsien

AU - Raleigh, Daniel P.

AU - Radford, Sheena E.

AU - Ashcroft, Alison E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The search for therapeutic agents that bind specifically to precursor protein conformations and inhibit amyloid assembly is an important challenge. Identifying such inhibitors is difficult because many protein precursors of aggregation are partially folded or intrinsically disordered, which rules out structure-based design. Furthermore, inhibitors can act by a variety of mechanisms, including specific or nonspecific binding, as well as colloidal inhibition. Here we report a high-throughput method based on ion mobility spectrometry-mass spectrometry (IMS-MS) that is capable of rapidly detecting small molecules that bind to amyloid precursors, identifying the interacting protein species and defining the mode of inhibition. Using this method we have classified a variety of small molecules that are potential inhibitors of human islet amyloid polypeptide (hIAPP) aggregation or amyloid-beta 1-40 aggregation as specific, nonspecific, colloidal or non-interacting. We also demonstrate the ability of IMS-MS to screen for inhibitory small molecules in a 96-well plate format and use this to discover a new inhibitor of hIAPP amyloid assembly.

AB - The search for therapeutic agents that bind specifically to precursor protein conformations and inhibit amyloid assembly is an important challenge. Identifying such inhibitors is difficult because many protein precursors of aggregation are partially folded or intrinsically disordered, which rules out structure-based design. Furthermore, inhibitors can act by a variety of mechanisms, including specific or nonspecific binding, as well as colloidal inhibition. Here we report a high-throughput method based on ion mobility spectrometry-mass spectrometry (IMS-MS) that is capable of rapidly detecting small molecules that bind to amyloid precursors, identifying the interacting protein species and defining the mode of inhibition. Using this method we have classified a variety of small molecules that are potential inhibitors of human islet amyloid polypeptide (hIAPP) aggregation or amyloid-beta 1-40 aggregation as specific, nonspecific, colloidal or non-interacting. We also demonstrate the ability of IMS-MS to screen for inhibitory small molecules in a 96-well plate format and use this to discover a new inhibitor of hIAPP amyloid assembly.

UR - http://www.scopus.com/inward/record.url?scp=84961291325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961291325&partnerID=8YFLogxK

U2 - 10.1038/nchem.2129

DO - 10.1038/nchem.2129

M3 - Article

C2 - 25515893

AN - SCOPUS:84961291325

VL - 7

SP - 73

EP - 81

JO - Nature Chemistry

JF - Nature Chemistry

SN - 1755-4330

IS - 1

ER -